End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
16.62
CNY
|
-2.41%
|
|
+3.68%
|
-13.26%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,108
|
3,796
|
3,293
|
-
|
-
|
Enterprise Value (EV)
1 |
5,108
|
3,796
|
3,293
|
3,293
|
3,293
|
P/E ratio
|
54
x
|
39.9
x
|
13.3
x
|
10.3
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
9.42
x
|
6.43
x
|
4.98
x
|
4.12
x
|
EV / Revenue
|
-
|
9.42
x
|
6.43
x
|
4.98
x
|
4.12
x
|
EV / EBITDA
|
-
|
33.3
x
|
25.5
x
|
19.3
x
|
15.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.66
x
|
3.02
x
|
2.77
x
|
2.51
x
|
Nbr of stocks (in thousands)
|
197,829
|
198,130
|
198,131
|
-
|
-
|
Reference price
2 |
25.82
|
19.16
|
16.62
|
16.62
|
16.62
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
402.9
|
512
|
661
|
800
|
EBITDA
1 |
-
|
113.9
|
129
|
171
|
213
|
EBIT
1 |
-
|
95.2
|
140
|
196
|
242
|
Operating Margin
|
-
|
23.63%
|
27.34%
|
29.65%
|
30.25%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
95.38
|
85.83
|
177.1
|
227.6
|
-
|
Net margin
|
-
|
21.3%
|
34.59%
|
34.44%
|
-
|
EPS
2 |
0.4786
|
0.4800
|
1.250
|
1.610
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
9.27%
|
11.8%
|
13.4%
|
13.6%
|
ROA (Net income/ Total Assets)
|
-
|
5.57%
|
7.2%
|
8.3%
|
9.5%
|
Assets
1 |
-
|
1,541
|
2,460
|
2,742
|
-
|
Book Value Per Share
2 |
-
|
5.230
|
5.500
|
6.000
|
6.610
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
45.7
|
90
|
63
|
54
|
Capex / Sales
|
-
|
11.34%
|
17.58%
|
9.53%
|
6.75%
|
Announcement Date
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Last Close Price
16.62
CNY Average target price
17
CNY Spread / Average Target +2.29% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.26% | 456M | | +17.96% | 44.96B | | +48.77% | 41.85B | | +1.17% | 42.65B | | -4.27% | 29.04B | | +11.42% | 26.08B | | -21.39% | 19.03B | | +4.86% | 12.75B | | +27.29% | 12.06B | | -3.50% | 11.75B |
Other Biotechnology & Medical Research
|